June 16, 2023 June 16, 2023Categories Press ReleasesMedia Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials
June 1, 2023 June 1, 2023Categories Press ReleasesPress Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials
May 17, 2023 May 17, 2023Categories Press ReleasesPress Release: ECOG-ACRIN announces the recipients of its 2023 scientific leadership and mentorship awards
May 11, 2023 May 11, 2023Categories Press ReleasesPress Release: Historic achievement for the ongoing InPACT penile cancer trial—100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
December 11, 2022 December 11, 2022Categories Press ReleasesPress Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)
December 6, 2022 December 6, 2022Categories Press ReleasesPress Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
October 28, 2022 October 28, 2022Categories Press ReleasesPress Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting
October 26, 2022 October 26, 2022Categories Press ReleasesPress Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib
